Turn Therapeutics Inc.
NASDAQ:TTRXBiotechnology
-$0.17 today
- Market cap
- $271.79M
- Beta
- 2.77
- P/E (TTM)
- -45.0
- EPS (TTM)
- -$0.13
Volume 0.05M
Average 0.04M
TTRX Other Current Assets
Current assets not reported separately, such as prepaid expenses.
Turn Therapeutics Inc.NASDAQ: TTRX
Other Current Assets · Q1 FY2026 · quarter ended Mar 2026
Other current assets of $235.17K in Q1 FY2026
Q1 FY2026 other current assets was $235.17K.
Context
- Other current assets amounted to 1.3% of total assets at the end of Q1 FY2026.
- Other current assets increased in 1 of the last 2 fiscal years.
- FY2025 was the lowest annual figure in the 3 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Current Assets history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- -100.0%
| Period | Period end | Other Current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | -100.0% |
| FY2024 | 2024-12-31 | 225.33K | +982.3% |
| FY2023 | 2023-12-31 | 20.82K | — |
Other Current Assets vs competitors
How TTRX compares with its peers on the latest reported figures
- TTRX's Mar 2026 other current assets of $235.17K is the 8th highest of the 9 companies compared; the peer median is $1.16M.
- Other current assets amounts to 1.3% of total assets for TTRX, versus a peer median of 1.2%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
IRDOpus Genetics, Inc. | Mar 2026 | $3.93M | +184.6% | +181.7% | 5.9% |
| Mar 2026 | $2.59M | -17.1% | -3.4% | 1.0% | |
| Mar 2026 | $2.04M | -15.9% | — | 1.1% | |
| Mar 2026 | $1.29M | +1568.7% | -32.5% | 0.7% | |
| Mar 2026 | $1.03M | — | — | 2.8% | |
| Apr 2026 | $950K | -18.7% | +149.3% | 6.4% | |
| Mar 2026 | $367.51K | -47.7% | +36.9% | 1.2% | |
TTRXTurn Therapeutics Inc. | Mar 2026 | $235.17K | — | — | 1.3% |
| Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding TTRX) | $1.16M | -16.5% | +36.9% | 1.2% | |
Competitors are the stored peer set for TTRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Turn Therapeutics Inc.
NASDAQ:TTRX
Intrinsic Alpha fair value
Locked
Current Price
$8.89
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.